Bio-Reference Laboratories Inc  

(Public, NASDAQ:BRLI)   Watch this stock  
Find more results for BRLI
29.07
+0.26 (0.89%)
Real-time:   1:38PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 28.76 - 29.07
52 week 24.13 - 37.97
Open 28.81
Vol / Avg. 29,826.00/217,741.00
Mkt cap 807.86M
P/E 20.44
Div/yield     -
EPS 1.42
Shares 27.73M
Beta 0.86
Inst. own 91%
Sep 16, 2014
Bio-Reference Laboratories Inc at Credit Suisse Small & Mid Cap Conference - 1:50PM EDT - Add to calendar
Aug 27, 2014
Q3 2014 Bio-Reference Laboratories Inc Earnings Call - Webcast
Aug 27, 2014
Q3 2014 Bio-Reference Laboratories Inc Earnings Release
Jul 10, 2014
Bio-Reference Laboratories Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '14) 2013
Net profit margin 6.87% 6.41%
Operating margin 12.55% 11.46%
EBITD margin - 14.22%
Return on average assets 13.33% 12.48%
Return on average equity 20.88% 18.37%
Employees 3,338 -
CDP Score - -

Address

481 Edward H. Ross Drive
ELMWOOD PARK, NJ 07407-3118
United States - Map
+1-201-7912600 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bio-Reference Laboratories, Inc. (Bio-Reference) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women�s health and correctional health care. The Company has a network f approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens. In August 2013, Bio-Reference Laboratories Inc completed the acquisition of a clinical laboratory in northern California. The Company acquired most of the assets of Hunter Laboratories, located in the Bay area.

Officers and directors

Marc D. Grodman M.D. Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Sam Singer Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Director
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Howard Dubinett Chief Operating Officer, Executive Vice President, Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Benincasa Independent Director
Age: 64
Bio & Compensation  - Reuters
Harry Elias Independent Director
Age: 83
Bio & Compensation  - Reuters
Gary Lederman Esq. Independent Director
Age: 79
Bio & Compensation  - Reuters
John Roglieri M.D. Independent Director
Age: 74
Bio & Compensation  - Reuters